Sandra Bax

Sandra is Manager of the Defective Medicines report Centre at the MHRA. She is a Chartered Chemist and a Qualified Person, with a MSc in Industrial Pharmaceutical Studies, and has over thirty years’ experience in the pharmaceutical industry. She has worked in large multi-nationals, as well as medium and small start up companies. As a QP, Sandra has expertise in GMP and pharmaceutical quality systems. Through her earlier roles in R&D Analytical Development she gained knowledge of stability testing of formulated products and active substances, and in New Product Introduction was involved in cleaning validation and technology transfer.